비교리스트

 카트 문의
시장보고서
상품코드
1551526

세계의 소 유방염 치료 시스템 시장

Bovine Mastitis Treatment System
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 366 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

소 유방염 치료 시스템 세계 시장은 2030년까지 23억 달러에 달할 것으로 전망

2023년 18억 달러로 추정되는 소 유방염 치료 시스템 세계 시장은 2023년부터 2030년까지 연평균 3.6% 성장하여 2030년에는 23억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 항생제 치료는 CAGR 4.2%를 기록할 것으로 예상되며, 분석 기간이 끝나면 13억 달러에 달할 것으로 예상됩니다. 기타 치료 유형 부문의 성장률은 분석 기간 동안 CAGR 2.9%로 추정됩니다.

미국 시장 4억 9,090만 달러로 추정, 중국은 CAGR 7.0%로 성장 전망

미국 소 유방염 치료 시스템 시장은 2023년 4억 9,090만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 4억 8,440만 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 7.0%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 1.2%와 2.7%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 1.9%의 성장률을 보일 것으로 예상됩니다.

세계 소 유방염 치료 시스템 시장 - 주요 동향 및 촉진요인 요약

소 유방염 치료 시스템은 어떻게 낙농업에 혁명을 일으키고 있는가?

소 유방염 치료 시스템은 젖소에게 영향을 미치는 가장 흔하고 비용이 많이 드는 질병 중 하나에 대한 효율적이고 효과적인 솔루션을 제공함으로써 낙농업에 혁명을 일으키고 있습니다. 유선의 염증인 유선염은 우유 생산량과 유질을 현저히 떨어뜨려 낙농가에 막대한 경제적 손실을 가져옵니다. 첨단 치료 시스템은 유선염을 보다 신속하고 정확하게 진단하고 치료하여 젖소의 건강과 낙농장의 수익성에 미치는 영향을 최소화할 수 있도록 설계되어 있습니다. 이러한 시스템에는 일반적으로 유방염의 초기 징후를 감지하고 적시에 개입할 수 있는 진단 도구와 항생제 및 기타 치료제를 감염된 부위에 직접 투여할 수 있는 치료 기기가 포함되어 있습니다. 이러한 시스템은 치료 과정을 자동화하고 각 젖소가 적절한 치료를 받을 수 있도록함으로써 동물 복지를 향상시킬 뿐만 아니라 우유 생산 효율을 높이고, 광범위 항생제 사용을 줄여 보다 지속가능한 낙농 경영에 기여할 수 있습니다.

어떤 기술 혁신이 소 유방염 치료 시스템의 기능을 향상시키는가?

소 유방염 치료 시스템의 기술 혁신은 진단, 정밀 치료 및 데이터 통합의 진보를 통해 그 기능을 향상시키고 있습니다. 최신 시스템에는 센서 및 농장 내 검사 키트와 같은 실시간 진단 기술이 탑재되어 유방염이 임상 증상이 나타나기 전에 유방염을 조기에 발견할 수 있습니다. 이러한 기술을 통해 낙농가들은 감염된 소를 더 빨리 격리하고 치료하여 목장 내 감염 확산을 방지할 수 있습니다. 자동 주입 시스템과 같은 정밀 치료 장비는 항생제나 항염증제를 감염된 유방에 직접 투여하여 과잉 치료의 위험을 줄이고 항생제 내성을 최소화할 수 있습니다. 또한, 이러한 치료 시스템은 농장 관리 소프트웨어와 통합되어 원활한 데이터 수집 및 분석이 가능합니다. 이러한 통합을 통해 낙농가는 각 소의 건강 상태를 추적하고, 치료 결과를 모니터링하고, 목장 관리에 대한 정보에 입각한 결정을 내릴 수 있습니다. 이러한 기술 혁신은 소 유방염 치료 시스템을 보다 효과적이고 효율적으로 만들고, 정밀 농업과 지속가능한 농업에 대한 중요성을 강조하고 있습니다.

소 유방염 치료 시스템은 유제품 생산과 동물 복지에 어떤 영향을 미칠까?

소 유방염 치료 시스템은 젖소의 건강을 개선하고 우유의 질과 양을 향상시킴으로써 낙농 생산과 동물 복지에 큰 영향을 미칩니다. 유방염의 조기 발견과 표적 치료를 가능하게함으로써 유방염의 중증도와 유병 기간을 줄여 우유 생산 손실을 최소화하고 전체 우군의 생산성을 향상시킵니다. 건강한 젖소는 더 높은 품질의 우유를 생산하며, 이는 업계 표준을 충족하고 수익성을 극대화하는 데 필수적입니다. 또한, 정밀 치료법의 사용은 항생제에 대한 의존도를 줄여 동물의 건강을 증진하고 항생제 내성 퇴치를 위한 전 세계 노력에 기여합니다. 동물 복지 측면에서 이러한 시스템은 소가 적시에 적절한 치료를 받을 수 있도록 보장하고 유방염과 관련된 통증과 불편함을 줄일 수 있습니다. 이러한 동물의 건강과 복지에 중점을 두는 것은 윤리적 농업 관행과 일치할 뿐만 아니라, 더 건강하고 생산성이 높은 가축을 육성함으로써 낙농 경영의 장기적인 지속가능성을 향상시킬 수 있습니다.

소 유방염 치료 시스템 시장의 성장을 촉진하는 추세는 무엇인가?

정밀 농업 기술의 채택 증가, 항생제 내성에 대한 인식 증가, 동물 복지와 지속가능한 농업에 대한 관심 증가 등 여러 가지 트렌드가 소 유방염 치료 시스템 시장의 성장을 촉진하고 있습니다. 낙농가들이 경영 효율성과 수익성을 높이기 위해 목장의 건강 상태를 보다 정확하게 관리할 수 있는 첨단 기술에 대한 수요가 증가하고 있습니다. 조기 발견과 표적 치료를 제공하는 소 유방염 치료 시스템은 정밀 농업을 향한 이러한 추세의 일환으로 점점 더 인기를 얻고 있습니다. 항생제 내성에 대한 전 세계적인 우려도 시장에 영향을 미치고 있으며, 규제 당국과 소비자 모두 가축에 대한 항생제 사용 감소를 촉구하고 있습니다. 이에 따라 항생제를 보다 적절하게 사용하고 내성을 조장하지 않으면서도 효과적으로 치료할 수 있는 시스템이 도입되고 있습니다. 또한, 동물 복지와 지속가능한 농법에 대한 관심이 높아지면서 젖소의 건강과 복지를 향상시킬 수 있는 시스템의 개발과 사용이 장려되고 있습니다. 이러한 추세는 효율성, 지속가능성, 동물 건강이 중요한 우선순위인 낙농업의 미래에 소 유방염 치료 시스템의 중요성이 커지고 있음을 보여줍니다.

조사 대상 기업 예시(총 42건)

  • Armenta Ltd.
  • Boehringer Ingelheim International GmbH
  • HIPRA, S.A.
  • Huvepharma EOOD
  • ImmuCell Corporation
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Thermo Fisher Scientific India Pvt.
  • Vetoquinol SA
  • Virbac S.A.
  • West Way Health
  • Zoetis Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.09.13

Global Bovine Mastitis Treatment System Market to Reach US$2.3 Billion by 2030

The global market for Bovine Mastitis Treatment System estimated at US$1.8 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Antibiotics Treatment, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Other Treatment Types segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$490.9 Million While China is Forecast to Grow at 7.0% CAGR

The Bovine Mastitis Treatment System market in the U.S. is estimated at US$490.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$484.4 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Bovine Mastitis Treatment System Market - Key Trends and Drivers Summarized

How Is Bovine Mastitis Treatment System Revolutionizing Dairy Farming?

Bovine mastitis treatment systems are revolutionizing dairy farming by providing targeted, efficient, and effective solutions to one of the most common and costly diseases affecting dairy cattle. Mastitis, an inflammation of the mammary gland, can significantly reduce milk production and quality, leading to substantial economic losses for dairy farmers. Advanced treatment systems are designed to diagnose and treat mastitis more quickly and accurately, helping to minimize the impact of the disease on both the herd's health and the farm's profitability. These systems typically include diagnostic tools that detect early signs of mastitis, enabling timely intervention, and treatment devices that deliver antibiotics or other therapies directly to the affected area. By automating the treatment process and ensuring that each cow receives the appropriate care, these systems not only improve animal welfare but also enhance milk production efficiency, reduce the use of broad-spectrum antibiotics, and contribute to more sustainable dairy farming practices.

What Innovations Are Enhancing the Functionality of Bovine Mastitis Treatment Systems?

Innovations in bovine mastitis treatment systems are enhancing their functionality through advancements in diagnostics, precision treatment, and data integration. Modern systems are increasingly incorporating real-time diagnostic technologies, such as sensors and on-farm testing kits, that can detect mastitis at its earliest stages, often before clinical symptoms are visible. These technologies enable farmers to isolate and treat affected cows more quickly, preventing the spread of infection within the herd. Precision treatment devices, such as automated infusion systems, allow for targeted delivery of antibiotics or anti-inflammatory agents directly to the infected udder quarters, reducing the risk of overtreatment and minimizing antibiotic resistance. Additionally, these treatment systems are being integrated with farm management software, enabling seamless data collection and analysis. This integration allows farmers to track the health of each cow, monitor treatment outcomes, and make informed decisions about herd management. These innovations are making bovine mastitis treatment systems more effective, efficient, and aligned with the growing emphasis on precision agriculture and sustainable farming practices.

How Do Bovine Mastitis Treatment Systems Impact Dairy Production and Animal Welfare?

Bovine mastitis treatment systems have a significant impact on dairy production and animal welfare by improving the health of dairy cows and enhancing the quality and quantity of milk produced. By enabling early detection and targeted treatment of mastitis, these systems help reduce the severity and duration of the disease, which in turn minimizes milk production losses and improves the overall productivity of the herd. Healthier cows produce higher quality milk, which is essential for meeting industry standards and maximizing profitability. Moreover, the use of precision treatment methods reduces the reliance on antibiotics, promoting better animal health and contributing to the global effort to combat antibiotic resistance. From an animal welfare perspective, these systems ensure that cows receive timely and appropriate care, reducing pain and discomfort associated with mastitis. This focus on animal health and well-being not only aligns with ethical farming practices but also enhances the long-term sustainability of dairy operations by fostering a healthier, more productive herd.

What Trends Are Driving Growth in the Bovine Mastitis Treatment Systems Market?

Several trends are driving growth in the bovine mastitis treatment systems market, including the increasing adoption of precision farming technologies, growing awareness of antibiotic resistance, and the rising focus on animal welfare and sustainable agriculture. As dairy farmers seek to improve operational efficiency and profitability, there is a growing demand for advanced technologies that enable more precise management of herd health. Bovine mastitis treatment systems that offer early detection and targeted therapy are becoming increasingly popular as part of this trend towards precision farming. The global concern over antibiotic resistance is also influencing the market, as both regulators and consumers push for reduced antibiotic use in livestock. This is driving the adoption of systems that allow for more judicious use of antibiotics, ensuring effective treatment without contributing to resistance. Additionally, the emphasis on animal welfare and sustainable farming practices is encouraging the development and use of systems that improve the health and well-being of dairy cows, which in turn supports more sustainable and ethical dairy production. These trends highlight the growing importance of bovine mastitis treatment systems in the future of dairy farming, where efficiency, sustainability, and animal health are key priorities.

Select Competitors (Total 42 Featured) -

  • Armenta Ltd.
  • Boehringer Ingelheim International GmbH
  • HIPRA, S.A.
  • Huvepharma EOOD
  • ImmuCell Corporation
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Thermo Fisher Scientific India Pvt. Ltd.
  • Vetoquinol SA
  • Virbac S.A.
  • West Way Health
  • Zoetis Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bovine Mastitis Treatment System - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Bovine Mastitis Driving Demand for Effective Treatment Solutions
    • Advancements in Diagnostic Technologies Enhancing Early Detection and Management
    • Development of Antibiotic-Free Treatments in Response to Consumer Health Concerns
    • Global Dairy Industry Growth and Its Impact on Mastitis Management Demand
    • Integration of Precision Farming Techniques to Improve Herd Health
    • Adoption of Telemedicine and Digital Tools for Veterinary Care
    • Technological Advances in Milking Systems and Their Role in Mastitis Prevention
    • Future Directions in Genomics and Breeding for Mastitis Resistance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bovine Mastitis Treatment System Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bovine Mastitis Treatment System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Intra-Mammary Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Intra-Mammary Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Intra-Mammary Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Systemic Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Systemic Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Systemic Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for On-Site Treatment End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for On-Site Treatment End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for On-Site Treatment End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Veterinary Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Veterinary Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Bovine Mastitis Treatment System by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: UK 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Spain 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Russia Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Russia 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Australia Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Australia 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 155: India Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: India Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: India 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 158: India Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: India 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 164: South Korea Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: South Korea Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: South Korea 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 173: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 182: Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 183: Latin America Historic Review for Bovine Mastitis Treatment System by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 194: Argentina Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Argentina Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Argentina 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 203: Brazil Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Brazil Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Brazil 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 212: Mexico Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Mexico Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Mexico 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 221: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Rest of Latin America Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Rest of Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 230: Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 231: Middle East Historic Review for Bovine Mastitis Treatment System by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 242: Iran Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Iran Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Iran 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 251: Israel Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Israel Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Israel 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 260: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Saudi Arabia Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Saudi Arabia 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 269: UAE Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: UAE Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: UAE 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 278: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Rest of Middle East Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Rest of Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Bovine Mastitis Treatment System Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 287: Africa Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Africa Historic Review for Bovine Mastitis Treatment System by Treatment Type - Antibiotics and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Africa 16-Year Perspective for Bovine Mastitis Treatment System by Treatment Type - Percentage Breakdown of Value Sales for Antibiotics and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Bovine Mastitis Treatment System by Administration Route - Intra-Mammary Administration and Systemic Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Bovine Mastitis Treatment System by Administration Route - Percentage Breakdown of Value Sales for Intra-Mammary Administration and Systemic Administration for the Years 2014, 2024 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Bovine Mastitis Treatment System by End-Use - On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Bovine Mastitis Treatment System by End-Use - Percentage Breakdown of Value Sales for On-Site Treatment End-Use and Veterinary Hospitals & Clinics End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제